Skip to main content

Diabetes & Weight Loss News

On June 27, the FDA approved Arena Pharmaceutical’s weight-loss drug Belviq (lorcaserin), the first weight-loss drug to be approved in the US in 13 years. Belviq is...
The Obesity Society's annual meeting has long been our favorite place to catch up on the basic science research behind this critical problem.
On May 14, HBO premiered its four-part documentary series on obesity, The Weight of the Nation . Each part – entitled “Consequences,” “Choices,” “Children in Crisis,”...
Several months after an FDA advisory committee delivered an overwhelmingly positive vote (20-2) in favor of approving Vivus’ Qnexa for the treatment of obesity, the...
(S)he said what?!?
We had the privilege of attending the inaugural Partnership for a Healthier America (PHA) Building a Healthier Future Summit in late 2011 in Washington, DC, where we...
diaTribe 's take on the recent New England Journal of Medicine's piece on weight gain - and loss!
As we have previously written, Vivus’ weight loss drug Qnexa is up for approval in the US in April of this year. Encouragingly, Vivus announced recently that, if...
In late November, the Centers for Medicare and Medicaid Services (the federal agency that administers the two public insurance programs) announced that Medicare would...
Recently, increasing evidence has suggested that weight-loss surgery (called “bariatric surgery”) can help improve type 2 diabetes management (or even cause its reversal...
Over the past several years, the use of GLP-1 drugs (such as Byetta and Victoza) together with basal insulins (such as Lantus and Levemir) as a treatment for type 2...
If you’ve been following our coverage of Orexigen’s obesity drug, Contrave, you’re likely aware that it has been through a regulatory rollercoaster over the past few...
Novo Nordisk’s Head of China Ron Christie divulges details on the state of diabetes care in the world’s most populous nation.
In previous issues, we’ve documented the arduous journey of Orexigen’s anti-obesity drug Contrave through the regulatory process. In December, an FDA Advisory Committee...
Larry Soler and Dr. James Gavin discuss Partnership for a Healthier America's efforts to fight childhood obesity.
Kelly reflects on her recent visit to Washington…
(S)he said what?!?
In late March, the International Diabetes Federation (IDF) released a "position statement" recommending the consideration of bariatric surgery to treat type 2 diabetes...
(S)he said what?!?
Puzzled by the recent FDA decisions? Dr. Sanjay Kaul discusses the regulatory environment for diabetes and obesity medications.

Pages